This protocol is judged by an institutional evaluation board, an impartial team that opinions any clinical trials involving humans. If a study will involve a Routine I drug, as soon as the board approves the protocol as ethical, the researchers really have to apply for an investigational new drug (IND) number in the FDA.If This really is the first